Michael LaBarre
Directeur Technique/Scientifique/R&D chez HALOZYME THERAPEUTICS, INC.
Fortune : 6 M $ au 30/04/2024
Profil
Michael J. LaBarre est directeur technique et vice-président principal de Halozyme Therapeutics, Inc. Au cours de sa carrière, le Dr LaBarre a occupé les postes de directeur de la biochimie analytique et protéique chez Biogen, Inc. et de directeur des sciences analytiques et de formulation chez IDEC Pharmaceuticals Corp. (une filiale de Biogen, Inc.) et vice-président du développement des produits chez Paramount BioSciences LLC. Le Dr LaBarre a obtenu un doctorat de l'université d'Arizona et un diplôme de premier cycle de l'université de Stony Brook.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2024 | 168 176 ( 0,13% ) | 6 M $ | 30/04/2024 |
Postes actifs de Michael LaBarre
| Sociétés | Poste | Début |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Anciens postes connus de Michael LaBarre
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/04/2006 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | 01/12/2003 |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Corporate Officer/Principal | - |
Formation de Michael LaBarre
| University of Arizona | Doctorate Degree |
| Stony Brook University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
